Many steps remain before older adults see the benefit of the Centers for Medicare and Medicaid Services’ upcoming talks with drugmakers.
Related posts:
G-7 nations call for thorough probe of Covid origins in China
FDA chief calls for probe of relationship between agency and Biogen
Vaccines will get full FDA approval, Fauci predicts
Top U.S. officials see booster shots as inevitable
Tensions mount between CDC and Biden health team over boosters
Nearly 60 percent of Americans now have antibodies from Covid-19 infection
The Biden administration is gambling that a little-studied vaccine can stop monkeypox
4 things to know about the bivalent booster campaign rollout
Indiana Supreme Court allows abortions to continue pending January hearing
South Dakota signals the end of an era on Medicaid expansion
Wyoming governor signs measure prohibiting abortion pills
Hutchinson deflects Tucker Carlson’s Covid vaccine question
